The research team focused on CD13, a protein expressed on the surface of leukemia cells. They engineered a CD13-binding nanobody (aCD13Nb) that strongly interacts with CD13, in addition to attaching ...

Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy ...

Coave's proprietary ALIGATER platform enables specific retargeting of AAV vectors to human receptors via a one-step chemical conjugation of peptide-based ligands at the surface of the capsid, ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Knowledge on the genetic basis of Parkinson's disease has grown tremendously since the discovery of the first monogenic form, ...

This important study presents the first identification of the odorant receptor for the trail pheromone in termites. The evidence supporting the conclusions is compelling, with state-of-the-art ...

A research team led by Prof. Zhou Rongbin from the University of Science and Technology of China (USTC) discovered the ...

Membrane proteins are sorted to the plasma membrane (PM) via Golgi-dependent trafficking. However, our recent studies challenged the essentiality of Golgi in the biogenesis of specific transporters.

Biotech firm Gilead Sciences has announced plans to voluntarily withdraw the US accelerated approval for Trodelvy ...

On Friday, Gilead Sciences, Inc. (NASDAQ:GILD) announced plans to voluntarily withdraw the U.S. accelerated approval for ...

Current spatially resolved transcriptomic technologies often struggle to achieve the necessary resolution to analyze individual cells within tissues ...